A handful of congressional Democrats have encouraged federal investigations into Abbott’s handling of contamination of formula products, which ultimately triggered a major recall and shut down a key facility in Sturgis, Mich., last February. A whistleblower alleged that Abbott employees falsified documents and covered up food safety violations from FDA inspectors before the recall.
The DOJ and FDA declined to comment on the investigation.
The Sturgis plant had produced about a fifth of the nation’s infant formula supply, and the shutdown triggered a massive shortage that rippled through the country and months later sparked a political crisis for President Joe Biden.
The DOJ investigation comes just weeks after Abbott and Ohio Gov. Mike DeWine announced the company̵[ads1]7;s plans to build a new $536 million manufacturing facility in the state to produce specialty and metabolic formulas for medically vulnerable children and adults who were hardest hit by the shortage. Abbott has struggled to ramp up production of the specialty formulas at the Sturgis facility, and recently pushed back the availability of a number of metabolic formulas to April.